Capital International, Inc./CA/

Position in AMGN — Amgen Inc

CIK 895213 Los Angeles, CA

Position in AMGN

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$140,060,577

+$785,917 QoQ

Shares Held

398,069

-6.4% QoQ

Ownership

0.074%

of shares outstanding

% of Portfolio

1.12%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2021

11 quarters on record

Voting authority Sole 34.82059642926226.ToString("F0")% Shared 0.ToString("F0")% None 65.17940357073773.ToString("F0")%

Healthcare · as of Mar 31, 2026

Capital International, Inc./CA/ holds $919,638,265 across 11 Drug Manufacturers - General names. AMGN ranks #3 (15.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AZN	Astrazeneca PLC	2,009,997	$396,411,608
2	LLY	ELI LILLY & Co	193,029	$177,542,283
3	AMGN	Amgen Inc This page	398,069	$140,060,577
4	ABBV	AbbVie Inc.	430,429	$93,614,003
5	GILD	Gilead Sciences, Inc.	355,956	$49,609,587
6	JNJ	Johnson & Johnson	156,815	$38,331,858
7	PFE	Pfizer Inc	374,286	$10,509,950
8	NVO	Novo Nordisk A S	155,415	$5,711,501

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$140,060,577	398,069	-6.4%	Shares	Defined	2026-05-13
2025-12-31	$139,274,660	425,513	+10.0%	Shares	Defined	2026-02-11
2025-09-30	$109,150,444	386,784	+22.8%	Shares	Defined	2025-11-13
2025-06-30	$87,916,527	314,876	+37.3%	Shares	Defined	2025-08-13
2025-03-31	$71,446,203	229,325	+37.1%	Shares	Defined	2025-05-12
2024-12-31	$43,595,688	167,264	+52.2%	Shares	Defined	2025-02-13
2024-09-30	$35,416,356	109,917	+1.1%	Shares	Defined	2024-11-13
2024-06-30	$33,983,311	108,764	+8.5%	Shares	Defined	2024-08-13
2024-03-31	$28,500,521	100,241	+1749.5%	Shares	Defined	2024-05-14
2021-12-31	$1,219,337	5,420	0.0%	Shares	Defined	2022-02-14
2021-09-30	$1,152,563	5,420	—	Shares	Defined	2021-11-15
No filing history on record for this holder in this stock.